A PYMNTS Company

AI, Pharmaceutical Sector, and EU Competition Law and Policy: What Does the Future Look Like?

BY | May 31, 2024

Artificial intelligence (“AI”) offers unprecedented opportunities to enhance the effectiveness of treatments and significantly reduce drug discovery and development timelines in the pharmaceutical industry. However, existing legal frameworks, including competition…

Artificial intelligence (“AI”) offers unprecedented opportunities to enhance the effectiveness of treatments and significantly reduce drug discovery and development timelines in the pharmaceutical industry. However, existing legal frameworks, including competition law, must be equipped to manage AI-driven innovations effectively. This research underlines the critical and immediate need for the EU to develop regulatory frameworks to adapt to the evolving AI landscape in pharmaceuticals. The s

...
THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 100.28.2.72

Please verify email or join us to access premium content!